Search

Search Constraints

You searched for: Author/Creator Yang, Yuching

Search Results

1. Role of Model‐Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling. (10th September 2019)

2. Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation. (10th November 2019)

3. Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making—A workshop summary. (18th September 2021)

4. Model‐Informed Drug Development Approaches to Assist New Drug Development in the COVID‐19 Pandemic. Issue 3 (4th December 2021)

5. Whole Body PBPK Modeling of Remdesivir and Its Metabolites to Aid in Estimating Active Metabolite Exposure in the Lung and Liver in Patients With Organ Dysfunction. Issue 3 (8th November 2021)

6. Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations. (1st August 2021)

8. Human radiolabeled mass balance studies supporting the FDA approval of new drugs. Issue 11 (23rd September 2022)

9. Model‐Informed Drug Development in Pediatric Dose Selection. (29th June 2021)

10. Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019. (21st May 2020)